
|Articles|May 12, 2008
Cimzia approved for signs and symptoms of Crohn's disease
UCB receives FDA approval for certolizumab pegol (Cimzia).
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
New Study Finds Compounded GLP-1s Remain Robust Despite End of Shortages
2
How Pharmacists Take Control of Medical Billing
3
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
4
COVID-19 Booster Comparison Shows Higher Antibody Levels With mRNA Vaccine
5






























